Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Mucositis 9Head and Neck Neoplasms 6Xerostomia 4Squamous Cell Carcinoma of Head and Neck 3Sexual Dysfunction, Physiological 3Stomatitis 2Radiation Injuries 2Prostatic Neoplasms 2Lymphoma 2Sexuality 1Radiotherapy-induced Oral Mucositis 1Radiation-induced Oral Mucositis 1Pain 1Oral Ulcer 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Neoplasms 1Mouth Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1

Interventions

Radiotherapy 1Fibroblast Growth Factor 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oral Ulcer × Radiotherapy × Other × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡